INS and obesity disorder: Celastrol treatment mitigates obesity-induced metabolic dysfunctions by enhancing insulin sensitivity in skeletal muscle via upregulation of GLUT4, improvement of mitochondrial function, and activation of antioxidant defense mechanisms (Abu Bakar et al., 2020).